Previous Close | 15.00 |
Open | 15.20 |
Bid | 15.20 x N/A |
Ask | 15.70 x N/A |
Day's Range | 15.20 - 15.20 |
52 Week Range | 14.90 - 19.90 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Nov 10, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Q4 2022 Paragon 28 Inc Earnings Call
Paragon 28, Inc. (FNA) delivered earnings and revenue surprises of -466.67% and 2.03%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ENGLEWOOD, Colo., March 02, 2023--Paragon 28, Inc. (NYSE: FNA) ("PARAGON"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter and year ended December 31, 2022.